5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

 

5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology
L

Treatment of 42 y/o with HER2+ Breast Cancer, T1b Lesions and Positive Lymph Nodes: Managing Axilla, Radiation, Residual Cancer Burden & Additional Systemic Therapy With TDM1

By 5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology FEATURING Laura Freedman, Ashley Dowdy, Lee Schwartzberg, Carey Anders
By 5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology FEATURING Laura Freedman, Ashley Dowdy, Lee Schwartzberg, Carey Anders
0 views
March 12, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray

Featured Video

02:58
Lilly Medical Affairs

A Heterogenous Disease with Varied Clinical Outcomes: HR+/HER2- MBC

Feat. J. O’Shaughnessy
Breast Cancers
13:02
5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

Treatment of 42 y/o With Grade 3 Invasive Ductal Carcinoma, ER/PR -,…

Feat. L. Freedman, A. Dowdy, L. Schwartzberg, C. Anders
19:25
5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

Treatment of 42 y/o with HER2+ Breast Cancer, T1b Lesions and Positi…

Feat. L. Freedman, A. Dowdy, L. Schwartzberg, C. Anders
16:23
5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

Treatment of Metastatic HER2+ Breast Cancer: Radiation Strategy for …

Feat. L. Freedman, A. Dowdy, L. Schwartzberg, C. Anders